Skip to main content
. 2020 Aug 27;12(9):2440. doi: 10.3390/cancers12092440
E2 Estrogen
ER Estrogen receptor
P4 Progesterone
PR Progesterone receptor
TNBC Triple negative breast cancer
WHI Women’s health initiative
HRT Hormone replacement therapy
HER2 Human epidermal growth factor receptor 2
MPA Medroxyprogesterone acetate
RANKL Receptor activator of nuclear factor kappa-B ligand
RANK Receptor activator of nuclear factor kappa-B
CCND1 Cyclin D1
HRE Hormone response element
PRE Progesterone response element
EGFR Epidermal growth factor receptor
MAPK Mitogen activated protein kinase
STAT Signal transducer and activator of transcription
mPR Membrane progesterone receptor
GPCR G protein coupled receptor
PAQR Progestin and adipoQ receptor
MAPR Membrane associated progesterone receptor
PGRMC1 Progesterone receptor membrane component 1
PGRMC2 Progesterone receptor membrane component 2
GLI-1 Glioma associated oncogene homolog 1
NF-kB Nuclear factor kappa B
OVX Ovariectomized
ACI August copenhagen irish
SPRM Selective progesterone receptor modulator
TPA Telapristone acetate
NET Norethisterone
CK2 Casein kinase 2
5αP 5α-dihydroprogesterone
3αHP 3α-dihydroprogesterone